Fig. 2From: How the National Health Insurance Coverage policy changed the use of lenvatinib for adult patients with advanced hepatocellular carcinoma: a retrospective cohort analysis with real world big dataGraphic illustration of the ITS model and the trend lines for data pointsBack to article page